Pandemics, shifting drug prices, government healthcare mandates, regulatory requirements, calls for consumer customization—challenges such as these have driven pharmaceutical & biopharma processors to look at ways to streamline operations and reduce costs to manufacture faster. One of the ways this is happening is through modular manufacturing, which allows organizations to produce a variety of products from a single facility with faster changeovers, increased flexibility, and improved overall equipment effectiveness.
Join us to discuss in this webinar, how the Virtual Twin of biomanufacturing processes and recipes, as well as the Virtual Twin of buildings, equipment and single-use kits, can help Life Sciences companies and CMOs to implement modular and flexible drug manufacturing and accelerate industrialization, scale-up and tech transfer.
Through practical use-cases, we will show how such an approach allows a facility to be broken down into functional building blocks or modules, creating their twin in a virtual world, creating opportunities to simplify, standardize, verify, and re-use designs as well as actual modules in different implementations, train operators and ease qualification and validation. Leading ultimately to more sustainable drug manufacturing.
